StockWatch
·

CHEMO PHARMA LABORATORIES LTD.

BSE: 506365

P/L Snapshot

Q1 FY27 · standalone

vs Q3 FY26·vs Q1 FY26
Revenue
0.07
+259.9%
Expenditure
0.05
-38.2%-99.5%
Net Profit
0.02
+124.3%+100.2%
OPM %
28.32%

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
-14.64-7.320.017.3414.66Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q1 FY27
Price Chart
Latest News

Corporate Events

Board MeetingSTARSOURCE
2026
28Sep

Board Meeting

The Board will consider the Annual General Meeting for FY 20…

BSE Filing ↗
Board MeetingSTARSOURCE
2026
1Sep

Board Meeting

To consider and approve the Notice of the 39th Annual Genera…

BSE Filing ↗
Board MeetingSTARSOURCE
2026
14Aug

Board Meeting

To consider and approve the Un-Audited Financial Results for…

BSE Filing ↗
Board MeetingSTARSOURCE
2026
29May

Board Meeting

To consider and approve the Audited Financial Results for th…

BSE Filing ↗
Board MeetingSTARSOURCE
2025
21Aug

Board Meeting

consider and approve the request letter dated 11th August, 2…

BSE Filing ↗
Board MeetingSTARSOURCE
2025
12Aug

Board Meeting

To consider and approve the Un-Audited Financial Results for…

BSE Filing ↗
Board MeetingSTARSOURCE
2025
29May

Board Meeting

consider and approve the Audited Financial Results for the q…

BSE Filing ↗
Board MeetingSTARSOURCE
2024
28Oct

Board Meeting

Consider and approve the Un-Audited Financial Statements for…

BSE Filing ↗
Board MeetingSTARSOURCE
2024
29Jul

Board Meeting

Consideration and approval of Un-Audited Financial Results f…

BSE Filing ↗
Board MeetingSTARSOURCE
2024
27May

Board Meeting

Consider and approve Audited Financial Results for the quart…

BSE Filing ↗